Tranzactioneaza Biocardia (US.BCDA) - 2.37 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 2.310 USD
Ask 2.380 USD
Minim 2.350 USD
Maxim 2.350 USD
Pret referinta 2.400
Volum -
Volum ultima zi 1
Max 52 sapt 5.690 USD
Min 52 sapt 0.300 USD

Descriere companie

BioCardia, Inc. (www.biocardia.com) is a clinical-stage regenerative medicine company. It develops novel autologous and allogeneic therapeutics for cardiovascular and pulmonary diseases. Its CardiAMP Cell Therapy System (CardiAMP) is its lead therapeutic program being advanced for two clinical indications. This cell therapy system is comprised of a cell potency screening test, a point of care cell processing platform, and a biotherapeutic delivery system. It is an autologous cell therapy being advanced for two indications in pivotal clinical trials. The CardiAMP Heart Failure Trial is a pivotal Phase III trial, which is designed to provide the primary support for the safety and efficacy of the CardiAMP Cell Therapy System for heart attack (BCDA-01) indication. The CardiAMP Chronic Myocardial Ischemia Trial is a pivotal Phase III trial, which is designed to provide the primary support for the safety and efficacy of the CardiAMP Cell Therapy System for chronic myocardial ischemia (BCDA-02) indication.

Informatii companie

Nume

BioCardia, Inc.